StopDownOpen the app

News · Agriculture & Food Systems

Ayana Bio and Zenfold buy Meati's fermentation equipment

By ·

Date
Company
Ayana Bio
What it does
Plant cell culture ingredients startup
Kind
News
Amount
$75,000
Based in
Boston
Sector
Agriculture & Food Systems

What they do

Ayana Bio is a Boston startup that grows plant cells in bioreactors to make high-value ingredients

What happened

It jointly bought 12 fermentation tanks from bankrupt Meati Foods for $75,000 with Zenfold Sustainable Technologies

Why it matters

The equipment will be shipped to India to set up a pilot facility for plant cell development by early 2027

The details

  • Ayana Bio and Zenfold Sustainable Technologies jointly bought Meati Foods' fermentation equipment for $75,000.
  • The equipment includes 12 fermentation tanks, each 25,000 litres, plus seed trains, totalling 300,000 litres of capacity.
  • The equipment was originally worth several million dollars when installed at Meati's Colorado facility.
  • Meati Foods entered an Assignment for the Benefit of Creditors (ABC) process in May 2025 and laid off most staff by end of 2025.
  • Meati was later acquired by Meati Holdings, but its core fermentation assets remained unsold in an online auction in spring 2026.
  • Ayana Bio and Zenfold will decommission and ship the equipment to Zenfold's facilities in India.
  • The equipment will establish a dedicated Ayana Bio pilot facility for plant cell development, with a target operational date of first half of 2027.
  • The pilot capabilities will also be accessible to other plant cell companies.

The bigger picture

  • Plant cell culture grows plant cells in bioreactors under controlled conditions to produce high-value compounds and secondary metabolites.
  • Advantages include consistent supply despite climate change, no pesticides, reduced land and water use, and higher yields.
  • The 25,000-litre fermenters provide an intermediate scale between pilot and Zenfold's existing 100,000-litre commercial runs, reducing technical and financial risk.
  • Ayana Bio's initial target ingredients include rosmarinic acid from sage, which is seen as a natural preservative alternative amid proposed bans on synthetic preservatives like BHA.

About the business

  • Ayana Bio is a Boston-based startup focused on plant cell culture to produce high-value ingredients.
  • It grows plant cells in bioreactors under controlled conditions to make compounds like rosmarinic acid, crocins, zeaxanthin, and lutein.
  • Initial target ingredients are rosmarinic acid from sage, crocins from saffron, and zeaxanthin and lutein from marigold.
  • Rosmarinic acid is positioned as a natural preservative alternative amid regulatory activity against synthetic preservatives.
  • Zenfold Sustainable Technologies is headquartered in Bengaluru with manufacturing and R&D in Bengaluru and Hyderabad.
  • Zenfold focuses on specialty and fine chemicals using green chemistry, biotransformation, and synthetic biology.
  • Zenfold already operates four 100,000-litre bioreactors.

What happens next

  • Ayana Bio and Zenfold will decommission and ship the equipment to Zenfold's facilities in India.
  • The equipment will establish a dedicated Ayana Bio pilot facility for plant cell development.
  • The pilot facility is targeted to be operational by the first half of 2027.
  • The pilot capabilities will also be accessible to other plant cell companies.

The deal

Type
asset purchase

Founders

  • Frank Jaksch, CEO

Other articles talking about it

Read it as a card in the app

Same day

All startup news on 15 September 2026 →